Platelet-to-lymphocyte ratio is associated with cardiovascular disease in continuous ambulatory peritoneal dialysis

Tianlei Chen1, Min Yang1

  • 1Department of Nephrology, The First People's Hospital of Changzhou, The Third Affiliated Hospital of Soochow University, Changzhou, Jiangsu 213000, PR China.

Insights

High platelet-to-lymphocyte ratio (PLR) is a significant predictor of cardiovascular disease (CVD) events in continuous ambulatory peritoneal dialysis (CAPD) patients. This simple test can help identify patients at higher risk for CVD events.

Area of Science:

  • Nephrology
  • Cardiology
  • Inflammation Biomarkers

Background:

  • Patients with chronic kidney disease (CKD) exhibit elevated cardiovascular disease (CVD) risk, often linked to systemic inflammation.
  • Platelet-to-lymphocyte ratio (PLR) is an emerging inflammatory marker.
  • The inflammatory status in continuous ambulatory peritoneal dialysis (CAPD) patients is a key factor in CVD development.

Purpose of the Study:

  • To investigate the association between PLR and the incidence of CVD events in CAPD patients.
  • To determine if PLR can serve as a predictive marker for CVD events in this population.

Main Methods:

  • A cohort of 70 stable CAPD patients was monitored from February 2014 to March 2017.
  • Demographic and baseline clinical laboratory data were collected.
  • Binary logistic regression analysis was employed to assess the relationship between PLR and CVD events.

Main Results:

  • During a median follow-up of 22 months, 40% of CAPD patients experienced CVD events.
  • Patients with CVD events showed significantly higher platelets, C-reactive protein, PLR, and neutrophil-to-lymphocyte ratio (NLR).
  • High PLR was identified as an independent predictor of CVD events (OR, 1.05; 95% CI, 1.02-1.08; p<0.01), whereas high NLR was not.

Conclusions:

  • PLR is independently associated with CVD events in CAPD patients.
  • Elevated PLR can predict the risk of CVD events.
  • PLR is an easily obtainable and potentially routine clinical test for risk assessment.
Abstract

Related Concept Videos

Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications01:25

Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications

Peritoneal dialysis (PD) is a medical process that removes waste products and excess fluid from the body using the peritoneal membrane as a natural filter.Peritoneal Dialysis MethodsSeveral methods can be used for peritoneal dialysis, including Acute Intermittent Peritoneal Dialysis, Continuous Ambulatory Peritoneal Dialysis, and Automated Peritoneal Dialysis, also known as Continuous Cyclic Peritoneal Dialysis.Acute Intermittent Peritoneal Dialysis (AIPD) is used for patients with uremic...
416
Peritoneal Dialysis III: Nursing Management01:25

Peritoneal Dialysis III: Nursing Management

Peritoneal dialysis, or PD, utilizes the peritoneal membrane as a filter to eliminate excess fluid and waste products. Effective nursing management is essential for ensuring patient safety, preventing complications, and promoting optimal function of the peritoneal dialysis process.Assessment and MonitoringNurses must thoroughly assess the patient before, during, and after each dialysis session. Regular monitoring includes vital signs, daily weight, fluid intake and output, and laboratory values...
548
Peritoneal Dialysis I: Introduction and Procedure01:30

Peritoneal Dialysis I: Introduction and Procedure

Peritoneal dialysis (PD) is a procedure that facilitates the exchange of solutes, waste products, electrolytes, and excess fluid between the blood in the peritoneal capillaries and a dialysis solution introduced into the peritoneal cavity.Principles of Peritoneal Dialysis (PD)Diffusion: Waste products such as urea and electrolytes move from high concentrations in the blood to low concentrations in the dialysate across the peritoneal membrane. This mechanism is driven by the concentration...
1.8K
Continuous Renal Replacement Therapy01:30

Continuous Renal Replacement Therapy

Continuous Renal Replacement Therapy, also known as CRRT, is a procedural treatment for acute kidney injury (AKI) that gradually removes uremic toxins and fluids while maintaining acid-base balance and stabilizing electrolytes. It is particularly useful for hemodynamically unstable patients. Unlike intermittent hemodialysis, which is faster, CRRT provides a gentler approach over 24 hours, closely mimicking the function of natural kidneys. However, CRRT is not ideal for patients with...
651
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
258